Search hospitals > Nevada > Reno
Cancer Care Specialists - Reno
Claim this profileReno, Nevada 89511
Conducts research for Cancer
Conducts research for Tumors
Conducts research for Leukemia
Conducts research for Colorectal Cancer
Conducts research for Germ Cell Tumors
22 reported clinical trials
2 medical researchers
Summary
Cancer Care Specialists - Reno is a medical facility located in Reno, Nevada. This center is recognized for care of Cancer, Tumors, Leukemia, Colorectal Cancer, Germ Cell Tumors and other specialties. Cancer Care Specialists - Reno is involved with conducting 22 clinical trials across 77 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.Area of expertise
1Cancer
Stage I
Stage IV
Stage II
2Tumors
Stage I
Stage II
Stage IV
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
147 reported clinical trials
225 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation7 years of reported clinical research
Expert in Tumors
Expert in Leukemia
52 reported clinical trials
109 drugs studied
Clinical Trials running at Cancer Care Specialists - Reno
Germ Cell Tumors
Ovarian Tumors
Testicular Carcinoma
Ovarian Carcinoma
Embryonal Carcinoma
Ovarian Choriocarcinoma
Testicular Choriocarcinoma
Testicular Tumor
Testicular Germ Cell Tumor
Tumors
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Chemotherapy + Radiation Therapy
for Brain Cancer
This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish spinal cord relapses, 2) utilizing higher dose chemotherapy followed by conventional RT in patients who did not respond to induction chemotherapy. Chemotherapy drugs, such as carboplatin, etoposide, ifosfamide, and thiotepa, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays or high-energy protons to kill tumor cells and shrink tumors. Studies have shown that patients with newly-diagnosed localized NGGCT, whose disease responds well to chemotherapy before receiving radiation therapy, are more likely to be free of the disease for a longer time than are patients for whom the chemotherapy does not efficiently eliminate or reduce the size of the tumor. The purpose of this study is to see how well the tumors respond to induction chemotherapy to decide what treatment to give next. Some patients will be given RT to the spine and a portion of the brain. Others will be given high dose chemotherapy and a stem cell transplant before RT to the whole brain and spine. Giving treatment based on the response to induction chemotherapy may lower the side effects of radiation in some patients and adjust the therapy to a more efficient one for other patients with localized NGGCT.
Recruiting1 award Phase 2
Questionnaire Choice
for Cancer Data Quality
The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.
Recruiting1 award N/A11 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cancer Care Specialists - Reno?
Cancer Care Specialists - Reno is a medical facility located in Reno, Nevada. This center is recognized for care of Cancer, Tumors, Leukemia, Colorectal Cancer, Germ Cell Tumors and other specialties. Cancer Care Specialists - Reno is involved with conducting 22 clinical trials across 77 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.